0001209191-23-012875.txt : 20230224 0001209191-23-012875.hdr.sgml : 20230224 20230224182036 ACCESSION NUMBER: 0001209191-23-012875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alspaugh Jonathan CENTRAL INDEX KEY: 0001868112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 23669270 MAIL ADDRESS: STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC. STREET 2: 805 LAS CIMAS PARKWAY, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-23 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001868112 Alspaugh Jonathan C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 0.44 2023-02-23 4 A 0 640000 0.00 A 2033-02-22 Common Stock 640000 640000 D The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 23, 2023, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ James Kastenmayer, by power of attorney 2023-02-24